The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Keratin‐18 and micro RNA ‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts
Abstract
Background & Aims: There is a demand for more sensitive, specific and predictive biomarkers for drug‐induced liver injury ( DILI ) than the gold standard used today, alanine aminotransferase ( ALT ). The aim of this study was to qualify novel DILI biomarkers (keratin‐18 markers M65/M30, micro RNA ‐122, glutamate dehydrogenase and alpha‐foetoprotein) in human DILI . Methods: Levels of the novel biomarkers were measured by enzyme‐linked immunosorbent assay or real‐time quantitative reverse‐transcription PCR ( qRT ‐PCR) in two human DILI cohorts: a human volunteer study with acetaminophen and a human immunodeficiency virus (HIV)/tuberculosis (TB) study. Results: In the acetaminophen study, serum M65 and micro RNA ‐122 levels were significantly increased at an earlier time point than ALT . Furthermore, the maximal elevation of M65 and micro RNA ‐122 exceeded the increase in ALT . In the HIV / TB study, all the analysed novel biomarkers increased after 1 week of treatment. In contrast to ALT , the novel biomarkers remained stable in a human cohort with exercise‐induced muscular injury. Conclusions: M65 and micro RNA ‐122 are potential biomarkers of DILI superior to ALT with respect to sensitivity and specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The apoptotic index, which incorporates full‐length serum cytokeratin 18 (CK18) and caspase‐cleaved CK18 levels, may also be more sensitive than serum ALT in detecting liver injury and also be of prognostic value.212,213”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [212]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
Plasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases
Zhang, Y., Jia, Y., Zheng, R., Guo, Y., Wang, Y., Guo, H., Fei, M., & Sun, S. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147850 · Cited by 415
Antoine, D. J., Williams, D. P., Kipar, A., Jenkins, R. E., Regan, S. L., Sathish, J. G., Kitteringham, N. R., & Park, B. K. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp235 · Cited by 223
Self-citation
Research works printed but not linked: 47
- 10.1111/j.1365-2036.2010.04320.x · DOI · Paper page
- 10.1172/JCI103055 · DOI · Paper page
- Lindena J, 1986, Catalytic enzyme activity concentration in tissues of man, dog, rabbit, guinea pig, rat and mouse. Approach to a quantitative diagnostic enzymology, III. Communication, J Clin Chem Clin Biochem, 24, 35
- 10.1111/j.1365-2125.2007.03001.x · DOI · Paper page
- 10.1161/01.CIR.11.6.871 · doi:10.1161/01.cir.11.6.871
- 10.2337/diabetes.53.11.2855 · DOI · Paper page
- 10.2337/diabetes.53.10.2623 · DOI · Paper page
- 10.1016/j.taap.2008.03.007 · DOI
- 10.1016/j.tox.2007.11.021 · DOI · Paper page
- 10.1016/j.drudis.2011.04.011 · DOI
- 10.1016/j.jhep.2011.12.019 · DOI · Paper page
- 10.1002/hep.24538 · DOI · Paper page
- 10.3892/ijmm.2012.1106 · doi:10.3892/ijmm.2012.1106
- 10.1002/hep.20511 · DOI · Paper page
- Moll R, 1991, Molecular diversity of cytokeratins: significance for cell and tumor differentiation, Acta Histochem Suppl, 41, 117
- 10.1073/pnas.0804549105 · DOI · Paper page
- 10.1186/1471-2164-8-166 · DOI · Paper page
- 10.1016/0009-8981(88)90356-7 · DOI
- 10.7326/0003-4819-80-2-156 · doi:10.7326/0003-4819-80-2-156
- 10.1002/lt.20886 · DOI
- 10.1185/030079906X148346 · DOI
- 10.1111/j.1478-3231.2011.02501.x · DOI · Paper page
- 10.1111/j.1440-1746.2007.05207.x · DOI · Paper page
- 10.1016/j.jhep.2005.11.027 · DOI · Paper page
- 10.1164/ajrccm.151.1.7812542 · DOI · Paper page
- 10.1038/clpt.2009.240 · DOI
- 10.1371/journal.pone.0027810 · DOI
- 10.1111/j.1478-3231.2006.01197.x · DOI
- 10.1158/1940-6207.CAPR-09-0094 · DOI · Paper page
- 10.1007/s00228-010-0862-x · DOI
- 10.1002/hep.26294 · DOI · Paper page
- 10.1111/j.1478-3231.2011.02528.x · DOI
- 10.1038/clpt.2012.40 · DOI · Paper page
- 10.1586/erm.10.14 · doi:10.1586/erm.10.14
- 10.1371/journal.pone.0037395 · DOI
- 10.1177/0192623312464436 · DOI
- 10.1373/clinchem.2009.131797 · DOI · Paper page
- 10.3748/wjg.v12.i8.1175 · doi:10.3748/wjg.v12.i8.1175
- 10.1309/14TY-2TDJ-1X0Y-1V6V · DOI · Paper page
- 10.1007/s00421-010-1774-2 · DOI
- 10.1080/03602530802341133 · DOI
- 10.1002/hep.20548 · DOI · Paper page
- Giboney PT, 2005, Mildly elevated liver transaminase levels in the asymptomatic patient, Am Fam Physician, 71, 1105
- 10.1046/j.1365-2125.2003.01969.x · DOI
- 10.1002/hep.24734 · DOI · Paper page
- 10.1371/journal.pone.0023937 · DOI · Paper page
- 10.1002/mc.20712 · DOI · Paper page
Cited by
Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update
(2016) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00052 · Cited by 744
Cardoso, A. L., Fernandes, A., Aguilar-Pimentel, J. A., de Angelis, M. H., Guedes, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.004 · Cited by 475
Drug-induced liver injury: recent advances in diagnosis and risk assessment
Kullak-Ublick, G. A., Andrade, R. J., Merz, M., End, P., Benesic, A., Gerbes, A. L., & Aithal, G. P. (2017) · Gut · doi:10.1136/gutjnl-2016-313369 · Cited by 438
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Church, R. J., Kullak‐Ublick, G. A., Aubrecht, J., Bonkovsky, H. L., Chalasani, N., Fontana, R. J., Goepfert, J. C., Hackman, F., King, N. M. P., Kirby, S., et al. (2019) · Hepatology · doi:10.1002/hep.29802 · Cited by 231
Self-citation
Metadata
- Authors
- Thulin, P., Nordahl, G., Gry, M., Yimer, G., Aklillu, E., Makonnen, E., Aderaye, G., Lindquist, L., Mattsson, C. M., Ekblom, B., Antoine, D. J., Park, B. K., Linder, S., Harrill, A. H., Watkins, P. B., Glinghammar, B., & Schuppe‐Koistinen, I.
- Affiliations
- AstraZeneca R&D Innovative Medicines Personalised Healthcare & Biomarkers Science for Life Laboratory Solna Sweden
- Former AstraZeneca R&D Global Safety Assessment Molecular Toxicology Södertälje Sweden
- Department of Pharmacology Faculty of Medicine Addis Ababa University Addis Ababa Ethiopia
- Division of Clinical Pharmacology Department of Laboratory Medicine Karolinska Institutet Karolinska University Hospital Huddinge Sweden
- Department of Internal Medicine Faculty of Medicine Addis Ababa University Addis Ababa Ethiopia
- Department of Medicine Division of Infectious Diseases Karolinska Institutet Karolinska University Hospital Huddinge Sweden
- Åstrand Laboratory of Work Physiology Swedish School of Sport and Health Sciences Karolinska Institutet Stockholm Sweden
- MRC Centre for Drug Safety Science Department of Molecular & Clinical Pharmacology University of Liverpool Liverpool UK
- Department of Oncology‐Pathology Karolinska Institutet Karolinska University Hospital Solna Sweden
- School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA
- AstraZeneca R&D Drug Safety & Metabolism Mölndal Sweden
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2013-10-14
- Volume
- 34
- Issue
- 3
- Pages
- 367-378
- ISSN
- 1478-3223
- 1478-3231
- Cited by
- 110
- References
- 4
- Language
- en
- Funders
- European and Developing Countries Clinical Trial Partnership (CG_TA.05.40204_005, CT.2005.32030.001)
- Swedish Research Council (348-2011-7383)
- National Center for Advancing Translational Sciences
- National Institutes of Health (UL1TR000083)
- Medical Research Council (G0700654)
- Wellcome Trust Research Fellowship
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Keratin‐18 and micro RNA ‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts. https://app.cochat.ai/papers/10.1111/liv.12322
- The paper
- Thulin, P., Nordahl, G., Gry, M., Yimer, G., Aklillu, E., Makonnen, E., Aderaye, G., Lindquist, L., Mattsson, C. M., Ekblom, B., Antoine, D. J., Park, B. K., Linder, S., Harrill, A. H., Watkins, P. B., Glinghammar, B., & Schuppe‐Koistinen, I. (2014). Keratin‐18 and micro RNA ‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts. Liver International. https://doi.org/10.1111/liv.12322
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.